Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02887521 · ClinicalTrials.gov registry record · Phase 3

Pulmonary Rehabilitation Before Lung Cancer Resection

A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.

Terminated
Registry status
Phase 3
Development phase
9
Enrollment target

NCT02887521 is a Phase 3 study that was terminated before completion, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02887521, a Phase 3 study, was terminated before completion, sponsored by Alliance for Clinical Trials in Oncology.

TERMINATED
Registry status
Phase 3
Development phase
9 participants
Enrollment target

Study Summary

This is a study funded by the National Institute of Health. The rationale for the need of this research is the lack of any well proven risk-reducing intervention that may decrease the morbidity of lung cancer resection in patients with COPD or that may improve their quality of life trajectory, a meaningful outcome in the overall disease progression. The proposed intervention is unique as it combines exercise and behavioral interventions that were pilot tested in a randomized single-blinded controlled design in the proposed population and proved feasible and potentially effective. The aim is to test the effect of the proposed rehabilitation on length of stay, pulmonary complications and quality of life trajectory.

Interventions

  • PROCEDURE surgery
  • OTHER education
  • DEVICE pedometer
  • PROCEDURE rehabilitation

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2018-02-28
Est. Completion 2019-09-25
Phase Phase 3

What the Registry Record Tells You About NCT02887521

The ClinicalTrials.gov registry entry for NCT02887521 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which surgery is the first listed.

NCT02887521 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02887521 about?

NCT02887521 is a clinical study titled "Pulmonary Rehabilitation Before Lung Cancer Resection". This is a study funded by the National Institute of Health. The rationale for the need of this research is the lack of any well proven risk-reducing intervention that may decrease the morbidity of lung cancer resection in patients with COPD or that may improve their quality of life trajectory, a mea...

What is the current status of trial NCT02887521?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 9 participants. The study started on 2018-02-28. Estimated completion is 2019-09-25.

What interventions are being tested in trial NCT02887521?

The interventions under investigation include: surgery (PROCEDURE), education (OTHER), pedometer (DEVICE), rehabilitation (PROCEDURE).

Who is sponsoring clinical trial NCT02887521?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.